Literature DB >> 2475779

Shared idiotypes expressed by human B-cell lymphomas.

R A Miller1, S Hart, M Samoszuk, C Coulter, S Brown, D Czerwinski, J Kelkenberg, I Royston, R Levy.   

Abstract

Each B-cell lymphoma expresses a surface immunoglobulin that contains unique antigenic determinants (idiotypes). We have produced 199 murine monoclonal antibodies reactive with the idiotypes isolated from 67 patients with follicular small-cleaved-cell lymphoma. These antiidiotype antibodies were analyzed for their ability to react with lymphoma cells from patients other than the one against which each antibody was made. Twenty of the 199 antiidiotype antibodies were reactive with lymphoma cells from more than one patient. Depending on the antibody, the frequency of idiotype sharing ranged from 0.6 to 6.2 percent of B-cell lymphoma tumors evaluated. Tumors could be grouped into distinct families on the basis of their reactivity with these antibodies. In the aggregate, the 20 antibodies reacted with a total of 49 of 150 B-cell lymphomas (33 percent), including 30 of 110 follicular small-cleaved-cell lymphomas (27 percent). Many of these shared idiotypes were expressed by more than one histopathological subtype of lymphoma. We conclude that a panel of antibodies reactive with shared idiotypes can be produced for patients with B-cell lymphoma, obviating the need to produce an antiidiotype antibody for each patient.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2475779     DOI: 10.1056/NEJM198909283211302

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  8 in total

Review 1.  The second century of the antibody. Molecular perspectives in regulation, pathophysiology, and therapeutic applications.

Authors:  J Braun; A Saxon; R Wall; S L Morrison
Journal:  West J Med       Date:  1992-08

2.  Immunoglobulin idiotype expression in reactive lymphoid tissues and B-cell lymphomas.

Authors:  M Shiota; K Kitamura; M Noda; Y Kawanishi; S Hart; R A Miller; S Mori
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 3.  Treatment of B-cell lymphoma using peptides. A novel concept.

Authors:  K S Lam
Journal:  West J Med       Date:  1993-05

4.  Characterization of a monoclonal anti-idiotype antibody to human anti-factor VIII antibodies.

Authors:  B C Lubahn; H M Reisner
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

Review 5.  Cancer nanomedicines: so many papers and so few drugs!

Authors:  Vincent J Venditto; Francis C Szoka
Journal:  Adv Drug Deliv Rev       Date:  2012-10-01       Impact factor: 15.470

6.  Chronic lymphocytic leukemia monitoring with a Lamprey idiotope-specific antibody.

Authors:  Hirotomo Nakahara; Brantley R Herrin; Matthew N Alder; Rosa Catera; Xiao-Jie Yan; Nicholas Chiorazzi; Max D Cooper
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

7.  Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.

Authors:  John M Timmerman; Julie M Vose; Debra K Czerwinski; Wen-Kai Weng; Diane Ingolia; Martha Mayo; Dan W Denney; Ronald Levy
Journal:  Leuk Lymphoma       Date:  2009-01

8.  Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice.

Authors:  Pier Adelchi Ruffini; Audun Os; Riccardo Dolcetti; Geir E Tjønnfjord; Ludvig A Munthe; Bjarne Bogen
Journal:  J Transl Med       Date:  2014-07-25       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.